Ethigen's AL-721 to be renamed
Egg lecithin nutritional supplement, current under evaluation at NIH as a potential AIDS therapy, will be renamed by Ethigen "to end confusion created by bootleggers selling imitation products," firm reports in press release. FDA has asked the company to rename its nutritional product in order to avoid an implied drug claim. The new name has not yet been selected.
You may also be interested in...
Indivior aims to cut costs by restructuring its US commercial operations and reducing discretionary spending, in order to improve flexibility in the face of the COVID-19 pandemic and to invest in R&D.
Look! Up in the sky! It’s a bird! It’s a plane! It’s … a COVID-19 test from Quest Diagnostics.
New directors at 4D Pharma, Neurogene And Zogenix.